A detailed history of Bridgewater Advisors Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Bridgewater Advisors Inc. holds 12,486 shares of NVO stock, worth $1.41 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
12,486
Previous 12,506 0.16%
Holding current value
$1.41 Million
Previous $1.79 Million 16.75%
% of portfolio
0.15%
Previous 0.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$119.07 - $145.42 $2,381 - $2,908
-20 Reduced 0.16%
12,486 $1.49 Million
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $1.53 Million - $1.84 Million
12,506 New
12,506 $1.79 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $256B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bridgewater Advisors Inc. Portfolio

Follow Bridgewater Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Advisors Inc. with notifications on news.